Finance

Beta
Lists
OMDA:NASDAQ
Omada Health Inc
$18.90
+1.61%
(+0.30) 1D
$18.90
0.00% (0.00)
After hours
Closed: Jun 25, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OMDA...
Open
$18.55
High
$19.02
Low
$18.41
Mkt. cap
1.12B
Avg. vol.
1.07M
Volume
908.39K
52-wk high
$26.92
52-wk low
$10.28
EPS
-$0.11
Shares outstanding
59.45M
No. of employees
943
Open
$18.55
High
$19.02
Low
$18.41
Mkt. cap
1.12B
Avg. vol.
1.07M
Volume
908.39K
52-wk high
$26.92
52-wk low
$10.28
EPS
-$0.11
Shares outstanding
59.45M
No. of employees
943
News stories
From sources across the web
About Omada Health Inc
CEO-
Employees943
Founded2011
HeadquartersSouth San Francisco, California, United States
SectorHealth care provider
Websiteomadahealth.com
Analyst ratings
Based on 9 analysts giving stock ratings to OMDA in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for OMDA in the last 3 months.
Highest
Current $18.90
$30.00 (+58.73%)
Average
$22.89 (+21.11%)
Lowest
$18.00 (-4.76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Craig Hettenbach
Morgan Stanley
Buy
Reiterated
$30.00
+58.7%
06/22/2026
David Roman
Goldman Sachs
Buy
Maintained
$25.00
+32.3%
06/10/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$20.00
+5.8%
05/08/2026
Sean Dodge
BMO Capital
Buy
Maintained
$20.00
+5.8%
05/08/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$24.00
+27%
05/08/2026
Stan Berenshteyn
Wells Fargo
Hold
Maintained
$18.00
-4.8%
05/08/2026
Constantine Davides
Citizens JMP
Buy
Maintained
$21.00
+11.1%
05/08/2026
Saket Kalia
Barclays
Buy
Reiterated
$20.00
+5.8%
05/08/2026
Ryan MacDonald
Needham
Buy
Reiterated
$28.00
+48.1%
05/08/2026
Lisa Gill
J.P. Morgan
Buy
Reiterated
$26.00
+37.6%
03/12/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.05 / -$0.04
+209.88%beat
Revenue / Est. (USD)
78.05M / 74.49M
+4.78%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
61.37M
68.03M
75.85M
78.05M
Cost of goods sold
21.06M
22.96M
22.18M
29.36M
Cost of revenue
21.06M
22.96M
22.18M
29.36M
Research and development expenses
10.02M
10.30M
11.55M
12.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.63M
37.28M
38.83M
40.78M
Operating expense
44.65M
47.58M
50.38M
53.47M
Total operating expenses
65.72M
70.54M
72.56M
82.83M
Operating income
-4.34M
-2.51M
3.28M
-4.78M
Other non operating income
-736.00K
-212.00K
-
-
EBT including unusual items
-5.31M
-3.18M
5.16M
-2.97M
EBT excluding unusual items
-5.31M
-1.07M
5.16M
-2.97M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.31M
-3.18M
5.16M
-2.97M
Net profit margin
-8.65%
-4.67%
6.80%
-3.81%
Earnings per share
-0.05
0.03
0.16
0.05
Interest and investment income
863.00K
2.01M
1.89M
1.83M
Interest expense
-1.09M
-353.00K
-13.00K
-18.00K
Net interest expenses
-231.00K
1.66M
1.88M
1.81M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.99M
-1.15M
4.73M
-3.27M
Gain or loss from assets sale
1.00K
-
6.00K
2.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of OMDA
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer